Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

QNRXQuoin Pharmaceuticals Ltd.

Nasdaq · CIK 0001671502
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end—
XBRL facts285

Identity from submissions API

NameQuoin Pharmaceuticals Ltd.
CIK0001671502
TickersQNRX
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end—
State of incorporationL3 Israel
Phone703 980 4182
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Quoin Pharmaceuticals, Ltd. (2021-10-29T04:00:00.000Z → 2026-09-01T04:00:00.000Z)
  • Cellect Biotechnology Ltd. (2016-05-06T04:00:00.000Z → 2021-10-15T04:00:00.000Z)
  • Cellect Biomed Ltd. (2016-04-08T04:00:00.000Z → 2016-07-07T04:00:00.000Z)
Business address
42127 PLEASANT FOREST COURT
ASHBURN
VA
20148-7349
VA
Mailing address
42127 PLEASANT FOREST COURT
ASHBURN
VA
20148-7349
VA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

587 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-128525 005-89873 261562650 34 20326
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-127778 005-89873 261556506 34 20718
2026-11-12 8-K FORM 8-K 5.07 0001104659-26-126328 001-37846 261548014 34 196106 1 1
2026-11-06 8-K FORM 8-K 2.02,9.01 0001104659-26-123960 001-37846 261533026 34 278471 1 1
2026-11-05 10-Q 10-Q 0001104659-26-123342 001-37846 261527585 34 5449760 1 1
2026-11-04 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003443 333-299668 261524452 33 2015
2026-11-04 8-K FORM 8-K 1.01,9.01 0001104659-26-122790 001-37846 261523825 34 583514 1 1
2026-11-04 424B5 424B5 0001104659-26-122776 333-299668 261523743 33 526984
2026-11-04 424B5 424B5 0001104659-26-122766 333-299668 261523659 33 424287
2026-10-28 S-3 FORM S-3 0001104659-26-119282 333-299668 261492163 33 1094426 1 1
2026-10-26 4/A OWNERSHIP DOCUMENT 0001104659-26-118917 4779
2026-10-20 8-K FORM 8-K 7.01,8.01,9.01 0001104659-26-117080 001-37846 261470472 34 223133 1 1
2026-10-14 8-K FORM 8-K 7.01,8.01,9.01 0001104659-26-115709 001-37846 261458241 34 212658 1 1
2026-10-07 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001778253-26-000004 005-89873 261447668 34 164839
2026-10-02 DEF 14A DEF 14A 0001104659-26-113301 001-37846 261437320 34 858780
2026-09-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003071 333-299021 261411878 33 2015
2026-09-25 424B3 424B3 0001104659-26-111012 333-299021 261411011 33 227618
2026-09-22 PRE 14A PRE 14A 0001104659-26-109641 001-37846 261397492 34 211797
2026-09-22 8-K FORM 8-K 7.01,8.01,9.01 0001104659-26-109639 001-37846 261397038 34 227248 1 1
2026-09-18 S-3 FORM S-3 0001104659-26-108970 333-299021 261391650 33 500736 1 1
2026-09-10 D xslFormDX01/primary_doc.xml 06b 0001104659-26-106751 021-597075 261371858 33 17206
2026-09-10 8-K FORM 8-K 7.01,8.01,9.01 0001104659-26-106705 001-37846 261371102 34 211206 1 1
2026-09-01 4 OWNERSHIP DOCUMENT 0001104659-26-104405 8123
2026-09-01 4 OWNERSHIP DOCUMENT 0001104659-26-104404 8119
2026-09-01 4 OWNERSHIP DOCUMENT 0001104659-26-104403 8177
2026-09-01 4 OWNERSHIP DOCUMENT 0001104659-26-104402 8158
2026-08-28 4 OWNERSHIP DOCUMENT 0001104659-26-103376 5721
2026-08-28 4 OWNERSHIP DOCUMENT 0001104659-26-103374 5767
2026-08-28 8-K FORM 8-K 1.01,3.02,7.01,8.01,9.01 0001104659-26-102917 001-37846 261334368 34 1226772 1 1
2026-08-20 8-K FORM 8-K 5.02,5.07,8.01 0001104659-26-099239 001-37846 261300108 34 207559 1 1
2026-08-14 8-K FORM 8-K 2.02,9.01 0001104659-26-097094 001-37846 261281295 34 281418 1 1
2026-08-14 10-Q 10-Q 0001104659-26-097064 001-37846 261281021 34 4868852 1 1
2026-07-16 ARS ARS 0001104659-26-084081 001-37846 261178693 34 17131934
2026-07-16 DEF 14A DEF 14A 0001104659-26-084078 001-37846 261178687 34 3571719 1 1
2026-07-06 PRE 14A FORM PRE 14A 0001104659-26-080828 001-37846 261156946 34 3233451 1 1
2026-06-23 8-K FORM 8-K 7.01,8.01,9.01 0001104659-26-076822 001-37846 261111202 34 220091 1 1
2026-06-04 8-K 8-K 7.01,8.01,9.01 0001104659-26-070501 001-37846 261064857 34 211977 1 1
2026-06-02 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-069556 005-89873 261057667 34 19974
2026-06-02 424B3 424B3 0001104659-26-069166 333-291385 261053488 33 26189
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-062875 005-89873 26990438 34 15572
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000935836-26-000279 005-89873 26989864 34 20841
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-003240 005-89873 26982866 34 9434
2026-05-07 8-K FORM 8-K 2.02,9.01 0001104659-26-057140 001-37846 26953441 34 275071 1 1
2026-05-07 10-Q 10-Q 0001104659-26-056941 001-37846 26952225 34 4330734 1 1
2026-04-29 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001716774-26-000012 005-89873 26910388 34 9196
2026-03-31 4 xslF345X06/ownership.xml 0000935836-26-000187 4111
2026-03-26 10-K 10-K 0001104659-26-035251 001-37846 26798838 34 9541130 1 1
2026-03-26 8-K FORM 8-K 2.02,9.01 0001104659-26-034951 001-37846 26794707 34 287875 1 1
2026-03-11 8-K FORM 8-K 7.01,8.01,9.01 0001104659-26-026410 001-37846 26743850 34 211595 1 1
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-016659 005-89873 26644784 34 20651
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-001060 005-89873 26640193 34 9314
2026-02-11 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-013497 005-89873 26621941 34 18815
2026-02-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-041438 005-89873 26608929 34 12206
2026-02-06 4 OWNERSHIP DOCUMENT 0001104659-26-011623 6122
2026-02-06 4 OWNERSHIP DOCUMENT 0001104659-26-011622 6070
2026-02-06 4 OWNERSHIP DOCUMENT 0001104659-26-011617 6102
2026-02-06 4 OWNERSHIP DOCUMENT 0001104659-26-011616 6062
2026-02-06 4 OWNERSHIP DOCUMENT 0001104659-26-011615 6068
2026-02-06 4 OWNERSHIP DOCUMENT 0001104659-26-011613 6056
2026-02-06 4 OWNERSHIP DOCUMENT 0001104659-26-011610 6027
2026-02-06 4 OWNERSHIP DOCUMENT 0001104659-26-011608 6050
2026-02-02 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-26-000065 005-89873 26589723 34 20571
2026-02-02 3 xslF345X02/ownership.xml 0000935836-26-000064 13024
2026-01-28 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001716774-26-000006 005-89873 26569799 34 8913
2026-01-20 8-K FORM 8-K 7.01,8.01,9.01 0001104659-26-005127 001-37846 26543889 34 224777 1 1
2025-12-16 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000719 005-89873 251575136 34 20070
2025-12-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-319730 005-89873 251573214 34 133232
2025-12-11 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001834913-25-000006 005-89873 251563787 34 8360
2025-12-05 424B3 424B3 0001104659-25-118662 333-291385 251551207 33 219562
2025-12-04 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003536 333-291385 251551085 33 1984
2025-12-03 4 OWNERSHIP DOCUMENT 0001104659-25-118190 6363
2025-12-02 CORRESP filename1.htm 0001104659-25-117689 18172
2025-11-17 8-K FORM 8-K 5.02,9.01 0001104659-25-113237 001-37846 251491749 34 265247 1 1
2025-11-12 8-K FORM 8-K 7.01,8.01,9.01 0001104659-25-109802 001-37846 251469047 34 218601 1 1
2025-11-07 S-3 FORM S-3 0001104659-25-108536 333-291385 251463316 33 468947 1 1
2025-11-06 10-Q 10-Q 0001104659-25-107785 001-37846 251458945 34 5340233 1 1
2025-11-06 8-K FORM 8-K 2.02,9.01 0001104659-25-107747 001-37846 251458574 34 271466 1 1
2025-10-27 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-102609 005-89873 251420302 34 19124
2025-10-23 D xslFormDX01/primary_doc.xml 06b 0001104659-25-101869 021-561902 251413690 33 13620
2025-10-21 8-K FORM 8-K 7.01,8.01,9.01 0001104659-25-101269 001-37846 251407534 34 213398 1 1
2025-10-15 4 OWNERSHIP DOCUMENT 0001104659-25-099782 16214
2025-10-15 8-K FORM 8-K 1.01,3.02,7.01,9.01 0001104659-25-099735 001-37846 251394989 34 1487245 1 1
2025-09-08 3 OWNERSHIP DOCUMENT 0001104659-25-088286 11749
2025-08-27 S-8 FORM S-8 0001104659-25-084044 333-289891 251265777 33 445398 1 1
2025-08-27 8-K FORM 8-K 5.02,9.01 0001104659-25-083248 001-37846 251259546 34 368836 1 1
2025-08-25 S-8 FORM S-8 0001104659-25-082553 333-289856 251252685 33 267211 1 1
2025-08-25 4 OWNERSHIP DOCUMENT 0001104659-25-082518 6259
2025-08-25 4 OWNERSHIP DOCUMENT 0001104659-25-082515 6314
2025-08-25 4 OWNERSHIP DOCUMENT 0001104659-25-082511 6268
2025-08-21 8-K FORM 8-K 3.03,5.02,5.07,7.01,8.01,9.01 0001104659-25-081480 001-37846 251241758 34 464247 1 1
2025-08-07 10-Q 10-Q 0001410578-25-001613 001-37846 251195123 34 4855554 1 1
2025-08-07 8-K FORM 8-K 2.02,9.01 0001104659-25-075244 001-37846 251195098 34 279138 1 1
2025-07-17 ARS ARS 0001104659-25-068712 001-37846 251131362 34 1341375
2025-07-17 DEF 14A DEF 14A 0001104659-25-068650 001-37846 251130628 34 4157984 1 1
2025-07-08 8-K FORM 8-K 5.02 0001104659-25-066451 001-37846 251111643 34 188766 1 1
2025-07-07 PRE 14A FORM PRE14A 0001104659-25-066171 001-37846 251108849 34 2185571 1 1
2025-06-25 8-K FORM 8-K 8.01 0001104659-25-062406 001-37846 251071160 34 188562 1 1
2025-06-20 8-K FORM 8-K 8.01 0001104659-25-061184 001-37846 251061858 34 190966 1 1
2025-06-13 4/A OWNERSHIP DOCUMENT 0001104659-25-059530 6218
2025-06-13 4/A OWNERSHIP DOCUMENT 0001104659-25-059529 6212
2025-06-04 8-K FORM 8-K 5.02 0001104659-25-056378 001-37846 251023027 34 188620 1 1
2025-06-03 4 OWNERSHIP DOCUMENT 0001104659-25-055943 6037
2025-06-02 4 OWNERSHIP DOCUMENT 0001104659-25-055634 5997
2025-06-02 4 OWNERSHIP DOCUMENT 0001104659-25-055633 6003
2025-06-02 4 OWNERSHIP DOCUMENT 0001104659-25-055631 5985
2025-06-02 4 OWNERSHIP DOCUMENT 0001104659-25-055629 5991
2025-06-02 4 OWNERSHIP DOCUMENT 0001104659-25-055627 6008
2025-06-02 4 OWNERSHIP DOCUMENT 0001104659-25-055626 5965
2025-05-23 8-K FORM 8-K 8.01,9.01 0001104659-25-052062 001-37846 25978390 34 211480 1 1
2025-05-21 8-K FORM 8-K 8.01,9.01 0001104659-25-051324 001-37846 25970967 34 206562 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-002285 005-89873 25952042 34 10800
2025-05-14 8-K FORM 8-K 2.02,9.01 0001104659-25-048579 001-37846 25946682 34 278955 1 1
2025-05-13 10-Q 10-Q 0001410578-25-001226 001-37846 25939903 34 4456081 1 1
2025-04-30 8-K FORM 8-K 8.01 0001104659-25-042661 001-37846 25897386 34 196703 1 1
2025-04-04 8-K FORM 8-K 3.03 0001104659-25-032189 001-37846 25813979 34 199655 1 1
2025-04-04 8-K FORM 8-K 3.03 0001104659-25-032004 001-37846 25812131 34 198311 1 1
2025-04-03 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000961 333-277016 25811885 33 1898
2025-04-02 8-K FORM 8-K 8.01 0001104659-25-031240 001-37846 25805765 34 200453 1 1
2025-03-28 POS AM POS AM 0001104659-25-029406 333-277016 25786865 33 450923
2025-03-20 8-K FORM 8-K 4.01,9.01 0001104659-25-026176 001-37846 25756908 34 207002 1 1
2025-03-13 10-K 10-K 0001410578-25-000336 001-37846 25736299 34 8402781 1 1
2025-03-13 8-K FORM 8-K 2.02,9.01 0001104659-25-023447 001-37846 25735705 34 279438 1 1
2025-02-27 8-K FORM 8-K 8.01 0001104659-25-018234 001-37846 25679032 34 199579 1 1
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-001226 005-89873 25630373 34 10649
2025-02-04 8-K FORM 8-K 8.01 0001104659-25-009137 001-37846 25588726 34 200321 1 1
2025-01-28 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-006734 005-89873 25564918 34 8979
2025-01-28 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-006733 005-89873 25564901 34 8986
2025-01-23 8-K FORM 8-K 8.01 0001104659-25-005619 001-37846 25550330 34 203089 1 1
2025-01-16 8-K FORM 8-K 8.01 0001104659-25-004132 001-37846 25536002 34 197488 1 1
2025-01-06 8-K FORM 8-K 8.01 0001104659-25-001350 001-37846 25511689 34 201103 1 1
2025-01-02 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-000397 005-89873 25503027 34 23508
2025-01-02 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-000396 005-89873 25503023 34 24486
2024-12-27 4 OWNERSHIP DOCUMENT 0001104659-24-132190 9973
2024-12-27 4 OWNERSHIP DOCUMENT 0001104659-24-132188 9967
2024-12-27 4 OWNERSHIP DOCUMENT 0001104659-24-132187 9949
2024-12-27 4 OWNERSHIP DOCUMENT 0001104659-24-132185 10010
2024-12-26 8-K FORM 8-K 1.01,8.01,9.01 0001104659-24-131554 001-37846 241576890 34 1030199 1 1
2024-12-23 424B4 424B4 0001104659-24-131090 333-283734 241570238 33 481314
2024-12-20 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-24-003894 333-283734 241569583 33 1893
2024-12-19 8-K FORM 8-K 8.01 0001104659-24-130017 001-37846 241561098 34 202323 1 1
2024-12-18 S-1/A FORM S-1/A 0001104659-24-129745 333-283734 241559135 33 695413
2024-12-17 CORRESP filename1.htm 0001104659-24-129311 13145
2024-12-17 UPLOAD filename1.pdf 0000000000-24-013864 333-283734 40238
2024-12-11 S-1 FORM S-1 0001104659-24-127623 333-283734 241541778 33 1389547
2024-12-11 424B3 424B3 0001104659-24-127418 333-277016 241540019 33 94003
2024-12-10 4 OWNERSHIP DOCUMENT 0001104659-24-127246 6017
2024-12-10 4 OWNERSHIP DOCUMENT 0001104659-24-127243 5988
2024-12-10 4 OWNERSHIP DOCUMENT 0001104659-24-127240 6046
2024-12-10 4 OWNERSHIP DOCUMENT 0001104659-24-127239 6013
2024-12-10 4 OWNERSHIP DOCUMENT 0001104659-24-127238 5974
2024-12-10 4 OWNERSHIP DOCUMENT 0001104659-24-127237 6006
2024-12-10 4 OWNERSHIP DOCUMENT 0001104659-24-127234 5994
2024-12-10 4 OWNERSHIP DOCUMENT 0001104659-24-127230 6001
2024-12-10 8-K FORM 8-K 3.03,5.02,5.07,8.01,9.01 0001104659-24-127208 001-37846 241538928 34 260734 1 1
2024-11-14 SC 13G/A sch13g.htm 0000929638-24-003926 005-89873 241465198 34 74768
2024-11-08 424B3 424B3 0001104659-24-115946 333-277016 241441660 33 873783
2024-11-08 8-K FORM 8-K 2.02,9.01 0001104659-24-115850 001-37846 241440434 34 274826 1 1
2024-11-08 10-Q 10-Q 0001410578-24-001804 001-37846 241437335 34 4974783 1 1
2024-10-31 8-K FORM 8-K 3.01 0001104659-24-113085 001-37846 241415692 34 203064 1 1
2024-10-24 DEF 14A DEF 14A 0001104659-24-111010 001-37846 241390529 34 1505405
2024-10-24 ARS ARS 0001104659-24-111009 001-37846 241390526 34 835971
2024-10-11 PRE 14A PRE 14A 0001104659-24-108085 001-37846 241368082 34 1485523
2024-09-30 8-K FORM 8-K 5.08,8.01 0001104659-24-103867 001-37846 241336471 34 199738 1 1
2024-09-11 4 OWNERSHIP DOCUMENT 0001104659-24-098940 11049
2024-09-05 4 OWNERSHIP DOCUMENT 0001104659-24-097257 10464
2024-09-05 4 OWNERSHIP DOCUMENT 0001104659-24-097254 10455
2024-08-14 8-K FORM 8-K 2.02,9.01 0001104659-24-089065 001-37846 241203222 34 272359 1 1
2024-08-12 424B3 424B3 0001104659-24-088382 333-277016 241197310 33 424076
2024-08-08 10-Q 10-Q 0001410578-24-001216 001-37846 241188034 34 4870115 1 1
2024-06-10 4 OWNERSHIP DOCUMENT 0001104659-24-070017 5013
2024-06-07 144 xsl144X01/primary_doc.xml 0001971857-24-000362 001-37846 241028255 33 4298
2024-05-10 424B3 424B3 0001104659-24-059902 333-277016 24934951 33 702489
2024-05-09 10-Q 10-Q 0001410578-24-000701 001-37846 24930787 34 4628315 1 1
2024-05-08 424B3 424B3 0001104659-24-058647 333-277016 24925708 33 41590
2024-05-03 8-K FORM 8-K 3.01 0001104659-24-057008 001-37846 24913680 34 199876 1 1
2024-04-09 8-K FORM 8-K 5.07 0001104659-24-045210 001-37846 24832719 34 199036 1 1
2024-04-03 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001410578-24-000363,2024-04-03 9999999995-24-000842 333-277016 24821504 33 1905
2024-04-02 DEFA14A DEFA14A 0001104659-24-042329 001-37846 24812670 34 17830
2024-03-29 POS AM POS AM 0001410578-24-000363 333-277016 24804231 33 7547363 1 1
2024-03-14 10-K 10-K 0001410578-24-000198 001-37846 24750867 34 7748285 1 1
2024-03-13 8-K FORM 8-K 2.02,9.01 0001104659-24-033990 001-37846 24746705 34 298093 1 1
2024-03-08 424B3 424B3 0001104659-24-032385 333-277016 24734339 33 688828
2024-03-08 424B3 424B3 0001104659-24-032382 333-269543 24734264 33 687715
2024-03-08 8-K FORM 8-K 1.01,8.01,9.01 0001104659-24-032379 001-37846 24734233 34 1016870 1 1
2024-03-06 424B4 424B4 0001410578-24-000142 333-277016 24726930 33 2684795
2024-03-06 8-K FORM 8-K 8.01 0001104659-24-031458 001-37846 24725778 34 198831 1 1
2024-03-04 424B3 424B3 0001410578-24-000130 333-277016 24716181 33 2684894
2024-02-27 DEF 14A DEF 14A 0001104659-24-027788 001-37846 24681797 34 595103
2024-02-14 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-02-14 17:30:00 9999999995-24-000474 333-277016 24641911 33 1930
2024-02-14 CORRESP filename1.htm 0001104659-24-023300 9582
2024-02-14 CORRESP filename1.htm 0001104659-24-023235 13963
2024-02-13 SC 13G/A sch13g.htm 0000929638-24-000576 005-89873 24631323 34 74234
2024-02-13 UPLOAD filename1.pdf 0000000000-24-001739 333-277016 40595
2024-02-13 S-1/A S-1/A 0001410578-24-000043 333-277016 24626985 33 13548092 1 1
2024-02-13 PRE 14A PRE 14A 0001104659-24-019936 001-37846 24626540 34 382295
2024-02-12 S-1 S-1 0001410578-24-000039 333-277016 24621200 33 13553825 1 1
2024-01-31 424B3 424B3 0001104659-24-008399 333-269543 24580129 33 266062
2024-01-30 8-K FORM 8-K 1.01,3.02,9.01 0001104659-24-008229 001-37846 24578166 34 477299 1 1
2023-12-18 424B3 424B3 0001104659-23-126977 333-269543 231494864 33 22181
2023-12-18 8-K FORM 8-K 8.01,9.01 0001104659-23-126974 001-37846 231494856 34 217567 1 1
2023-11-09 424B3 424B3 0001104659-23-116376 333-269543 231393759 33 984539
2023-11-09 10-Q 10-Q 0001410578-23-002320 001-37846 231393719 34 5098387 1 1
2023-11-09 8-K FORM 8-K 2.02,9.01 0001104659-23-116370 001-37846 231393706 34 292156 1 1
2023-11-07 424B3 424B3 0001104659-23-115326 333-269543 231385070 33 40172
2023-11-06 8-K FORM 8-K 3.03,5.07 0001104659-23-114757 001-37846 231380193 34 199201 1 1
2023-11-01 424B3 424B3 0001104659-23-113438 333-269543 231369213 33 82267
2023-11-01 8-K FORM 8-K 5.02,5.07,8.01 0001104659-23-113433 001-37846 231369043 34 244447 1 1
2023-10-30 4 OWNERSHIP DOCUMENT 0001104659-23-112572 6000
2023-10-30 4 OWNERSHIP DOCUMENT 0001104659-23-112570 6014
2023-10-30 4 OWNERSHIP DOCUMENT 0001104659-23-112568 6032
2023-10-30 4 OWNERSHIP DOCUMENT 0001104659-23-112565 6072
2023-10-30 4 OWNERSHIP DOCUMENT 0001104659-23-112563 6043
2023-10-30 4 OWNERSHIP DOCUMENT 0001104659-23-112562 6020
2023-10-30 4 OWNERSHIP DOCUMENT 0001104659-23-112560 6038
2023-10-30 4 OWNERSHIP DOCUMENT 0001104659-23-112558 6026
2023-10-19 DEFA14A DEFA14A 0001104659-23-110161 001-37846 231335340 34 18292
2023-09-14 424B3 424B3 0001104659-23-100809 333-269543 231255579 33 194521
2023-09-13 8-K FORM 8-K 1.01,9.01 0001104659-23-100115 001-37846 231251180 34 385886 1 1
2023-09-12 ARS ARS 0001104659-23-099830 001-37846 231248943 34 1563433
2023-09-12 DEF 14A DEF 14A 0001104659-23-099826 001-37846 231248940 34 1300702
2023-09-01 PRE 14A PRE 14A 0001104659-23-097648 001-37846 231231890 34 1300122
2023-08-03 424B3 424B3 0001104659-23-087340 333-269543 231140921 33 429676
2023-08-03 10-Q 10-Q 0001410578-23-001531 001-37846 231139311 34 4831438 1 1
2023-08-02 8-K FORM 8-K 2.02,8.01,9.01 0001104659-23-086860 001-37846 231136742 34 287553 1 1
2023-07-18 424B3 424B3 0001104659-23-082042 333-269543 231094771 33 38830
2023-07-14 8-K/A FORM 8-K/A 3.03 0001104659-23-081285 001-37846 231089738 34 196861 1 1
2023-06-28 424B3 424B3 0001104659-23-075757 333-269543 231051470 33 38810
2023-06-28 8-K FORM 8-K 3.03 0001104659-23-075754 001-37846 231051457 34 197877 1 1
2023-05-12 424B3 424B3 0001104659-23-059800 333-269543 23916471 33 49198
2023-05-12 8-K FORM 8-K 8.01 0001104659-23-059796 001-37846 23916415 34 196733 1 1
2023-05-09 424B3 424B3 0001104659-23-057715 333-269543 23901822 33 404735
2023-05-09 10-Q 10-Q 0001410578-23-000940 001-37846 23901548 34 4458533 1 1
2023-05-08 8-K FORM 8-K 2.02,9.01 0001104659-23-057256 001-37846 23898885 34 268618 1 1
2023-04-07 424B3 424B3 0001104659-23-042860 333-269543 23807606 33 39971
2023-04-07 8-K FORM 8-K 3.01 0001104659-23-042859 001-37846 23807605 34 200282 1 1
2023-03-22 424B3 424B3 0001104659-23-035193 333-269543 23750838 33 1716805
2023-03-17 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001410578-23-000269,2023-03-17 9999999995-23-000604 333-269543 23744818 33 1871
2023-03-15 POS AM POS AM 0001410578-23-000269 333-269543 23734692 33 7740181 1 1
2023-03-15 S-8 FORM S-8 0001104659-23-032715 333-270555 23734661 33 313576
2023-03-15 10-K 10-K 0001410578-23-000267 001-37846 23734636 34 7768732 1 1
2023-03-09 8-K FORM 8-K 2.02,9.01 0001104659-23-030189 001-37846 23717689 34 286288 1 1
2023-03-07 3 OWNERSHIP DOCUMENT 0001104659-23-029718 4768
2023-03-07 3/A OWNERSHIP DOCUMENT 0001104659-23-029715 4564
2023-03-07 3/A OWNERSHIP DOCUMENT 0001104659-23-029712 4581
2023-03-07 3/A OWNERSHIP DOCUMENT 0001104659-23-029711 4602
2023-03-07 3/A OWNERSHIP DOCUMENT 0001104659-23-029710 4558
2023-03-03 SC 13G schedule13g.htm 0000929638-23-000798 005-89873 23704263 34 79314
2023-02-28 424B3 424B3 0001104659-23-026303 333-269543 23678227 33 517973
2023-02-28 424B3 424B3 0001104659-23-026294 333-266476 23678223 33 518375
2023-02-28 424B3 424B3 0001104659-23-026286 333-264305 23678218 33 517111
2023-02-28 8-K FORM 8-K 1.01,7.01,9.01 0001104659-23-026247 001-37846 23678127 34 800647 1 1
2023-02-23 424B4 424B4 0001410578-23-000149 333-269543 23655718 33 2735823
2023-02-14 SC 13G/A QUOIN.txt 0000769993-23-000282 005-89873 23627365 34 24056
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021120 005-89873 23624745 34 64784
2023-02-10 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-02-10 16:00:00 9999999995-23-000380 333-269543 23614399 33 1858
2023-02-09 CORRESP filename1.htm 0001104659-23-017723 8453
2023-02-09 CORRESP filename1.htm 0001104659-23-017722 7338
2023-02-09 S-1/A S-1/A 0001410578-23-000082 333-269543 23600855 33 13833594 1 1
2023-02-08 CORRESP filename1.htm 0001104659-23-014723 21368
2023-02-07 UPLOAD filename1.pdf 0000000000-23-001272 43747
2023-02-03 S-1 S-1 0001410578-23-000057 333-269543 23582909 33 14484637 1 1
2023-01-03 3 OWNERSHIP DOCUMENT 0001104659-23-000145 5623
2023-01-03 3 OWNERSHIP DOCUMENT 0001104659-23-000143 4811
2023-01-03 3 OWNERSHIP DOCUMENT 0001104659-23-000140 5629
2023-01-03 3 OWNERSHIP DOCUMENT 0001104659-23-000138 4780
2023-01-03 3 OWNERSHIP DOCUMENT 0001104659-23-000135 5664
2023-01-03 3 OWNERSHIP DOCUMENT 0001104659-23-000133 5618
2023-01-03 3 OWNERSHIP DOCUMENT 0001104659-23-000131 4788
2022-11-10 424B3 424B3 0001104659-22-116972 333-266476 221376097 33 496058
2022-11-10 424B3 424B3 0001104659-22-116970 333-264305 221376091 33 489503
2022-11-10 6-K 6-K 0001410578-22-003102 001-37846 221375679 34 6014027 1 1
2022-11-07 424B3 424B3 0001104659-22-115352 333-266476 221365074 33 38788
2022-11-07 424B3 424B3 0001104659-22-115350 333-264305 221365072 33 37880
2022-11-07 6-K FORM 6-K 0001104659-22-115349 001-37846 221365065 34 21109
2022-10-28 424B3 424B3 0001104659-22-112080 333-266476 221338580 33 29281
2022-10-28 424B3 424B3 0001104659-22-112079 333-264305 221338578 33 28025
2022-10-28 6-K FORM 6-K 0001104659-22-112077 001-37846 221338570 34 10768
2022-09-21 424B3 424B3 0001104659-22-102003 333-266476 221257431 33 1238125
2022-09-21 424B3 424B3 0001104659-22-102000 333-264305 221257419 33 1236907
2022-09-21 6-K FORM 6-K 0001104659-22-101995 001-37846 221257389 34 1223737
2022-08-31 D xslFormDX01/primary_doc.xml 06b 0001458511-22-000001 021-457530 221216264 33 11956
2022-08-18 424B3 424B3 0001104659-22-092518 333-266476 221177273 33 538623
2022-08-18 424B3 424B3 0001104659-22-092516 333-264305 221177270 33 537064
2022-08-18 6-K 6-K 0001410578-22-002665 001-37846 221177265 34 6816896 1 1
2022-08-12 SC 13G SC 13G 0001104659-22-089784 005-89873 221158340 34 111775
2022-08-11 POS EX POS EX 0001104659-22-089066 333-264305 221154013 33 39326
2022-08-11 424B3 424B3 0001104659-22-089065 333-266476 221154010 33 1822876
2022-08-11 424B3 424B3 0001104659-22-089064 333-264305 221154008 33 1827341
2022-08-11 6-K FORM 6-K 0001104659-22-089063 001-37846 221154002 34 1703675
2022-08-09 424B4 424B4 0001410578-22-002138 333-266476 221145722 33 2713915
2022-08-05 EFFECT xslEFFECTX01/primary_doc.xml F-1,,2022-08-05 09:00:00 9999999995-22-002284 333-266476 221142387 33 1859
2022-08-05 F-1MEF F-1MEF 0001104659-22-086492 333-266561 221138861 33 310635
2022-08-04 CORRESP filename1.htm 0001104659-22-086063 7555
2022-08-04 CORRESP filename1.htm 0001104659-22-086060 7077
2022-08-04 F-1/A F-1/A 0001410578-22-002035 333-266476 221135488 33 9139924 1 1
2022-08-03 UPLOAD filename1.pdf 0000000000-22-008201 40439
2022-08-03 F-1 F-1 0001410578-22-002024 333-266476 221130752 33 9794994 1 1
2022-07-15 424B3 424B3 0001104659-22-080006 333-264305 221084250 33 369160
2022-07-15 6-K FORM 6-K 0001104659-22-080005 001-37846 221084249 34 352580
2022-06-30 RW RW 0001104659-22-076351 333-265596 221058617 NE 7761
2022-06-17 424B3 424B3 0001104659-22-072061 333-264305 221022263 33 188551
2022-06-17 6-K FORM 6-K 0001104659-22-072060 001-37846 221022260 34 164267
2022-06-14 F-3 FORM F-3 0001104659-22-071066 333-265596 221015749 33 925368
2022-06-13 424B3 424B3 0001104659-22-070382 333-264305 221010859 33 31801
2022-06-13 6-K FORM 6-K 0001104659-22-070379 001-37846 221010856 34 13474
2022-06-06 424B3 424B3 0001104659-22-068319 333-264305 22996724 33 262692
2022-06-06 6-K FORM 6-K 0001104659-22-068318 001-37846 22996722 34 256410
2022-05-23 424B3 424B3 0001104659-22-063830 333-264305 22951407 33 492590
2022-05-23 6-K FORM 6-K 0001104659-22-063825 001-37846 22951374 34 475515
2022-04-28 424B3 424B3 0001104659-22-052393 333-264305 22867989 33 30764
2022-04-28 6-K FORM 6-K 0001104659-22-052385 001-37846 22867931 34 14343
2022-04-26 424B3 424B3 0001104659-22-049766 333-264305 22851160 33 2003583
2022-04-22 EFFECT xslEFFECTX01/primary_doc.xml F-1,,2022-04-22 16:00:00 9999999995-22-001069 333-264305 22847209 33 1858
2022-04-22 CORRESP filename1.htm 0001104659-22-048788 7851
2022-04-21 UPLOAD filename1.pdf 0000000000-22-004301 40389
2022-04-15 F-1 F-1 0001410578-22-000921 333-264305 22828839 33 7755511 1 1
2022-04-14 20-F FORM 20-F 0001104659-22-045620 001-37846 22825876 34 9749096 1 1
2022-04-13 6-K FORM 6-K 0001104659-22-045491 001-37846 22824779 34 18556
2022-03-28 6-K FORM 6-K 0001104659-22-038338 001-37846 22773110 34 92418
2022-03-10 SC 13G/A QUOIN PHARMACEUTICALS, LTD. 0000769993-22-000244 005-89873 22728876 34 23664
2022-03-08 6-K FORM 6-K 0001104659-22-031667 001-37846 22722808 34 1742557
2022-02-14 SC 13G/A AMENDED SC 13G 0001387131-22-001862 005-89873 22630184 34 103430
2022-02-10 SC 13G QUOIN PHARMACEUTICALS LTD. 0000769993-22-000159 005-89873 22614498 34 23619
2022-02-08 6-K FORM 6-K 0001104659-22-012886 001-37846 22598620 34 794081
2022-01-31 6-K FORM 6-K 0001104659-22-009666 001-37846 22574578 34 139626
2022-01-12 6-K FORM 6-K 0001104659-22-003289 001-37846 22525131 34 290596
2021-12-20 6-K FORM 6-K 0001104659-21-151319 001-37846 211503306 34 792182
2021-11-23 6-K FORM 6-K 0001104659-21-143092 001-37846 211439519 34 1297576
2021-11-12 SC 13G SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-21-010999 005-89873 211402586 34 101259
2021-10-29 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-21-055261 001-37846 211361053 34 339556
2021-10-15 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-21-053035 001-37846 211326114 34 29363
2021-09-27 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-21-049924 001-37846 211279245 34 70892
2021-09-20 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-21-048834 001-37846 211263298 34 10315
2021-09-17 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-21-048656 001-37846 211261454 34 480943
2021-09-10 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-21-047311 001-37846 211245948 34 11148
2021-09-02 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-21-046402 001-37846 211233710 34 30728
2021-08-24 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-21-044599 001-37846 211202443 34 1968408 1 1
2021-08-13 6-K e620872_6k-cb.htm 0001193805-21-001182 001-37846 211173415 34 7155241
2021-08-12 EFFECT xslEFFECTX01/primary_doc.xml F-4,,2021-08-12 15:00:00 9999999995-21-003177 333-257144 211169525 33 1754
2021-08-10 CORRESP filename1.htm 0001193805-21-001147 7357
2021-08-10 F-4/A e620857_f4a-cellect.htm 0001193805-21-001146 333-257144 211159641 33 7041099
2021-08-06 F-4/A e620839_f4a-cellect.htm 0001193805-21-001121 333-257144 211150348 33 7097079
2021-08-05 CORRESP filename1.htm 0001193805-21-001120 12483
2021-08-03 25-NSE xslF25X02/primary_doc.xml 0001354457-21-000895 001-37846 211140272 34 3016
2021-07-30 UPLOAD filename1.pdf 0000000000-21-009384 44210
2021-07-16 CORRESP filename1.htm 0001193805-21-001036 19543
2021-07-16 F-4/A e620802_f4a-cellect.htm 0001193805-21-001035 333-257144 211095575 33 4679364
2021-06-30 UPLOAD filename1.pdf 0000000000-21-008075 45651
2021-06-17 6-K CURRENT REPORT 0001213900-21-032776 001-37846 211022799 34 33156
2021-06-16 F-4 e620681_f4-cellect.htm 0001193805-21-000886 333-257144 211021974 33 8059991 1
2021-06-03 6-K FORM 6-K 0001213900-21-030754 001-37846 21992416 34 9888
2021-04-19 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-21-021998 001-37846 21833270 34 26897
2021-03-29 20-F ANNUAL REPORT 0001213900-21-018137 001-37846 21779747 34 5830166 1
2021-03-29 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-21-018135 001-37846 21779730 34 232061
2021-03-24 6-K FORM 6-K 0001213900-21-017552 001-37846 21769273 34 3422621
2021-02-16 SC 13G/A SC 13G/A 0001104659-21-023190 005-89873 21633513 34 73148
2021-02-11 6-K/A AMENDMENT NO. 1 TO FORM 6-K 0001213900-21-008349 001-37846 21617821 34 1438179 1
2021-01-13 SC 13G CELLECT BIOTECHNOLOGY LTD. 0000902664-21-000169 005-89873 21525152 34 75950
2020-11-20 6-K FORM 6-K 0001213900-20-038375 001-37846 201330494 34 133517
2020-11-09 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-20-035709 001-37846 201296199 34 10516
2020-11-02 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-20-034369 001-37846 201278881 34 10252
2020-10-29 6-K FORM 6-K 0001213900-20-033819 001-37846 201270594 34 28581
2020-10-22 6-K FORM 6-K 0001213900-20-032699 001-37846 201251701 34 32465
2020-10-20 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-20-032325 001-37846 201248310 34 764992
2020-10-13 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-20-030939 001-37846 201234463 34 856373
2020-09-25 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-20-028441 001-37846 201200149 34 375116
2020-09-21 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-20-027449 001-37846 201185266 34 30302
2020-08-12 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-20-021524 001-37846 201094136 34 530882
2020-08-06 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-20-020520 001-37846 201080105 34 37839
2020-08-04 20-F/A AMENDMENT NO. 1 TO FORM 20-F 0001213900-20-020139 001-37846 201073003 34 69117
2020-06-03 6-K FORM 6-K 0001213900-20-013990 001-37846 20939379 34 10679
2020-05-27 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-20-013495 001-37846 20912868 34 13614
2020-05-21 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-20-013237 001-37846 20902210 34 114421
2020-05-18 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-20-012764 001-37846 20888101 34 30360
2020-05-12 424B3 PROSPECTUS SUPPLEMENT 0001213900-20-011807 333-229083 20868613 33 88390
2020-05-12 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-20-011805 001-37846 20868563 34 67185
2020-05-11 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-20-011527 001-37846 20862417 34 34306
2020-04-27 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-20-010140 001-37846 20817299 34 34796
2020-04-22 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-20-009823 001-37846 20808006 34 1152527
2020-04-22 SC 13D/A AMENDMENT NO. 2 TO SCHEDULE 13D 0001213900-20-009811 005-89873 20807846 34 38401
2020-04-03 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-20-008495 001-37846 20771692 34 172109
2020-04-03 20-F ANNUAL REPORT 0001213900-20-008493 001-37846 20771661 34 7578872 1
2020-04-02 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-20-008412 001-37846 20767396 34 24030
2020-03-04 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-20-005359 001-37846 20685744 34 66501
2020-02-14 SC 13G/A SC 13G/A 0001193125-20-038322 005-89873 20620399 34 121103
2020-01-27 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-20-001905 001-37846 20549596 34 273371
2020-01-17 SC 13G SC 13G 0001104659-20-004930 005-89873 20532361 34 104302
2020-01-10 SC 13G CELLECT BIOTECHNOLOGY LTD. 0000902664-20-000160 005-89873 20520465 34 81944
2020-01-10 424B5 PROSPECTUS SUPPLEMENT 0001213900-20-000728 333-219614 20519532 33 722229
2020-01-10 6-K FORM 6-K 0001213900-20-000726 001-37846 20519522 34 8461
2020-01-10 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-20-000724 001-37846 20519517 34 323016
2020-01-08 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-20-000459 001-37846 20514628 34 23743
2020-01-07 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-20-000322 001-37846 20512068 34 40093
2020-01-06 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-20-000253 001-37846 20509670 34 13404
2020-01-03 SC 13G/A SABBY 13G-A APOP 1.03.20 0001535610-20-000009 005-89873 20504208 34 15054
2019-12-30 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-19-027135 001-37846 191314750 34 11389
2019-12-23 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-19-026782 001-37846 191303414 34 36744
2019-11-25 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-19-024613 001-37846 191246663 34 385498
2019-11-19 6-K FORM 6-K 0001213900-19-023961 001-37846 191228977 34 134391
2019-11-07 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-19-022273 001-37846 191198271 34 28235

Latest XBRL company facts

One latest value per concept from companyfacts (285 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 70.29M 2026-08-12 2026 Q2 10-Q 2026-08-14 0001104659-26-097064
dei EntityPublicFloat Entity Public Float USD 5.40M 2025-06-30 2025 FY 10-K 2026-03-26 0001104659-26-035251
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 881,550 2025-01-01 2025-12-31 DEF 14A 2026-07-16 0001104659-26-084078
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 858,289 2025-01-01 2025-12-31 DEF 14A 2026-07-16 0001104659-26-084078
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 1.60M 2025-01-01 2025-12-31 DEF 14A 2026-07-16 0001104659-26-084078
ecd PeoTotalCompAmt PeoTotalCompAmt USD 1.51M 2025-01-01 2025-12-31 DEF 14A 2026-07-16 0001104659-26-084078
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 2.42 2025-01-01 2025-12-31 DEF 14A 2026-07-16 0001104659-26-084078
ffd NetFeeAmt NetFeeAmt USD 13,050 2026-10-26 S-3 2026-10-28 0001104659-26-119282
ffd TtlFeeAmt TtlFeeAmt USD 13,050 2026-10-26 S-3 2026-10-28 0001104659-26-119282
ffd TtlOfferingAmt TtlOfferingAmt USD 150.00M 2026-10-26 S-3 2026-10-28 0001104659-26-119282
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-10-26 S-3 2026-10-28 0001104659-26-119282
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-10-26 S-3 2026-10-28 0001104659-26-119282
ifrs-full AdditionalPaidinCapital AdditionalPaidinCapital ILS 127.00M 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment ILS 329,000 2020-01-01 2020-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full AdditionsToRightofuseAssets AdditionsToRightofuseAssets ILS 56,000 2020-01-01 2020-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full AdjustmentsForDecreaseIncreaseInOtherAssets AdjustmentsForDecreaseIncreaseInOtherAssets ILS 19,000 2019-01-01 2019-06-30 2020 Q2 6-K/A 2021-02-11 0001213900-21-008349
ifrs-full AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables ILS -835,000 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full AdjustmentsForDepreciationAndAmortisationExpense AdjustmentsForDepreciationAndAmortisationExpense ILS 181,000 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full AdjustmentsForFairValueGainsLosses AdjustmentsForFairValueGainsLosses ILS -397,000 2018-01-01 2018-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full AdjustmentsForFinanceCosts AdjustmentsForFinanceCosts ILS 25,000 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full AdjustmentsForIncreaseDecreaseInOtherOperatingPayables AdjustmentsForIncreaseDecreaseInOtherOperatingPayables ILS 292,000 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables ILS 1.40M 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full AdjustmentsForReconcileProfitLoss AdjustmentsForReconcileProfitLoss ILS 2.48M 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full AdjustmentsForSharebasedPayments AdjustmentsForSharebasedPayments ILS 430,000 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full Assets Assets ILS 11.78M 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full AssetsOtherThanCashOrCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013 AssetsOtherThanCashOrCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013 ILS 3,000 2018-01-01 2018-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full AverageForeignExchangeRate AverageForeignExchangeRate pure 3.215 2020-01-01 2020-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full BasicAndDilutedEarningsLossPerShare BasicAndDilutedEarningsLossPerShare ILS 0.049 2020-01-01 2020-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full BasicEarningsLossPerShareFromContinuingOperations BasicEarningsLossPerShareFromContinuingOperations ILS/shares 0.025 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full CashAndCashEquivalents CashAndCashEquivalents ILS 8.71M 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full CashFlowsFromUsedInFinancingActivities CashFlowsFromUsedInFinancingActivities ILS -104,000 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full CashFlowsFromUsedInInvestingActivities CashFlowsFromUsedInInvestingActivities ILS 29,000 2020-01-01 2020-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full CashFlowsFromUsedInOperatingActivities CashFlowsFromUsedInOperatingActivities ILS -7.90M 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full CashFlowsFromUsedInOperations CashFlowsFromUsedInOperations ILS 7.90M 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full ComprehensiveIncome ComprehensiveIncome ILS -9.85M 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full ConsiderationPaidReceived ConsiderationPaidReceived ILS 23.27M 2016-07-01 2016-07-28 2019 FY 20-F 2020-04-03 0001213900-20-008493
ifrs-full CurrentAssets CurrentAssets ILS 9.86M 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full CurrentLeaseLiabilities CurrentLeaseLiabilities ILS 369,000 2020-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full CurrentLiabilities CurrentLiabilities ILS 3.27M 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full CurrentPrepaidExpenses CurrentPrepaidExpenses ILS 213,000 2020-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full DepreciationAndAmortisationExpense DepreciationAndAmortisationExpense ILS 206,000 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full DepreciationRightofuseAssets DepreciationRightofuseAssets ILS 369,000 2020-01-01 2020-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full DescriptionOfExpectedVolatilityShareOptionsGranted DescriptionOfExpectedVolatilityShareOptionsGranted pure 0.778 2019-01-01 2019-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full DescriptionOfRiskFreeInterestRateShareOptionsGranted DescriptionOfRiskFreeInterestRateShareOptionsGranted pure 0.021 2019-01-01 2019-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full DisposalsPropertyPlantAndEquipment DisposalsPropertyPlantAndEquipment ILS -96,000 2020-01-01 2020-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full EffectOfExchangeRateChangesOnCashAndCashEquivalents EffectOfExchangeRateChangesOnCashAndCashEquivalents ILS -243,000 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full Equity Equity ILS 5.72M 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full EquityAndLiabilities EquityAndLiabilities ILS 11.78M 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full ExpectedDividendAsPercentageShareOptionsGranted ExpectedDividendAsPercentageShareOptionsGranted pure 0 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed ILS 196,000 2019-01-01 2019-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full FinanceCosts FinanceCosts ILS 4.08M 2020-01-01 2020-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full FinanceIncome FinanceIncome ILS 6.99M 2019-01-01 2019-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full FinancialLiabilitiesAtFairValue FinancialLiabilitiesAtFairValue ILS 3.67M 2019-02-28 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss ILS -232,000 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full GeneralAndAdministrativeExpense GeneralAndAdministrativeExpense ILS 8.11M 2020-01-01 2020-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full IncreaseDecreaseInCashAndCashEquivalents IncreaseDecreaseInCashAndCashEquivalents ILS -8.25M 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full IncreaseDecreaseThroughExerciseOfOptions IncreaseDecreaseThroughExerciseOfOptions ILS 158,000 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full IncreaseDecreaseThroughSharebasedPaymentTransactions IncreaseDecreaseThroughSharebasedPaymentTransactions ILS 430,000 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full InterestExpenseOnLeaseLiabilities InterestExpenseOnLeaseLiabilities ILS 88,000 2020-01-01 2020-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full InterestReceivedClassifiedAsOperatingActivities InterestReceivedClassifiedAsOperatingActivities ILS 8,000 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full IssueOfEquity IssueOfEquity ILS 9.19M 2020-01-01 2020-12-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full KeyManagementPersonnelCompensationShorttermEmployeeBenefits KeyManagementPersonnelCompensationShorttermEmployeeBenefits ILS 3.43M 2020-01-01 2020-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full LeaseLiabilities LeaseLiabilities ILS 366,000 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full MinimumFinanceLeasePaymentsPayable MinimumFinanceLeasePaymentsPayable ILS 183,000 2017-12-31 2017 FY 20-F 2018-03-19 0001213900-18-003140
ifrs-full NetAssetsLiabilities NetAssetsLiabilities ILS -3.72M 2019-06-30 2019 Q2 6-K 2019-08-13 0001213900-19-015431
ifrs-full NoncurrentAssets NoncurrentAssets ILS 2.33M 2020-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full NoncurrentLeaseLiabilities NoncurrentLeaseLiabilities ILS 202,000 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full NoncurrentLeasePrepayments NoncurrentLeasePrepayments ILS 1.34M 2018-12-31 2019 Q2 6-K 2019-08-13 0001213900-19-015431
ifrs-full NoncurrentLiabilities NoncurrentLiabilities ILS 2.78M 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full NoncurrentPayables NoncurrentPayables ILS 1.22M 2020-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full NumberOfSharesAuthorised NumberOfSharesAuthorised shares 500.00M 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full NumberOfSharesIssued NumberOfSharesIssued shares 392.17M 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full NumberOfSharesOutstanding NumberOfSharesOutstanding shares 392.17M 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full OperatingExpense OperatingExpense ILS 8.68M 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full OtherCurrentPayables OtherCurrentPayables ILS 2.42M 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full OtherCurrentReceivables OtherCurrentReceivables ILS 1.14M 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full OtherIncome OtherIncome ILS -13.99M 2020-01-01 2020-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full OtherNoncurrentReceivables OtherNoncurrentReceivables ILS 50,000 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full OtherPayables OtherPayables ILS 12,000 2017-12-31 2017 FY 20-F 2018-03-19 0001213900-18-003140
ifrs-full OtherReceivables OtherReceivables ILS 30,000 2018-12-31 2018 FY 20-F 2019-03-18 0001213900-19-004363
ifrs-full ParValuePerShare ParValuePerShare USD/shares 0.776 2019-06-02 2019 Q2 6-K 2019-08-13 0001213900-19-015431
ifrs-full PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities ILS 214,000 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full ProceedsFromCurrentBorrowings ProceedsFromCurrentBorrowings ILS 110,000 2021-04-01 2021-04-13 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full ProceedsFromExerciseOfOptions ProceedsFromExerciseOfOptions ILS 110,000 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full ProceedsFromIssuingShares ProceedsFromIssuingShares ILS 9.19M 2020-01-01 2020-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities ILS 34,000 2020-01-01 2020-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full ProfitLoss ProfitLoss ILS 9.85M 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full ProfitLossFromOperatingActivities ProfitLossFromOperatingActivities ILS 8.68M 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full PropertyPlantAndEquipment PropertyPlantAndEquipment ILS 1.05M 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities ILS 3,000 2020-01-01 2020-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full ResearchAndDevelopmentExpense ResearchAndDevelopmentExpense ILS 2.71M 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full ReserveOfSharebasedPayments ReserveOfSharebasedPayments ILS 16.94M 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full RestrictedCashAndCashEquivalents RestrictedCashAndCashEquivalents ILS 322,000 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full RetainedEarnings RetainedEarnings ILS -128.79M 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full RightofuseAssets RightofuseAssets ILS 1.51M 2020-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full RightofuseAssetsIncreaseDecreaseInRevaluationSurplus RightofuseAssetsIncreaseDecreaseInRevaluationSurplus ILS -183,000 2020-01-01 2020-06-30 2020 Q2 6-K/A 2021-02-11 0001213900-21-008349
ifrs-full SellingGeneralAndAdministrativeExpense SellingGeneralAndAdministrativeExpense ILS 5.97M 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full ShareIssueRelatedCost ShareIssueRelatedCost ILS 13.97M 2017-09-01 2017-09-07 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full ShorttermDepositsClassifiedAsCashEquivalents ShorttermDepositsClassifiedAsCashEquivalents ILS 3.65M 2018-06-30 2018 Q2 6-K 2018-08-09 0001213900-18-010586
ifrs-full ShorttermEmployeeBenefitsAccruals ShorttermEmployeeBenefitsAccruals ILS 810,000 2020-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full TaxRateEffectOfForeignTaxRates TaxRateEffectOfForeignTaxRates pure 0.23 2020-01-01 2020-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full TradeAndOtherCurrentPayables TradeAndOtherCurrentPayables ILS 2.58M 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full TradeAndOtherCurrentPayablesToTradeSuppliers TradeAndOtherCurrentPayablesToTradeSuppliers ILS 490,000 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full TradeAndOtherCurrentReceivables TradeAndOtherCurrentReceivables ILS 15,000 2020-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full TradeAndOtherReceivables TradeAndOtherReceivables ILS 284,000 2020-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full TreasuryShares TreasuryShares ILS 9.43M 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
ifrs-full UndiscountedOperatingLeasePaymentsToBeReceived UndiscountedOperatingLeasePaymentsToBeReceived ILS 822,000 2020-12-31 2020 FY 20-F 2021-03-29 0001213900-21-018137
ifrs-full WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16 WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16 pure 0.07 2019-06-30 2019 Q2 6-K 2019-08-13 0001213900-19-015431
ifrs-full WeightedAverageShares WeightedAverageShares shares 391.49M 2021-01-01 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
us-gaap AccountsPayableAndOtherAccruedLiabilities Accounts Payable and Other Accrued Liabilities USD 250,000 2021-12-31 2022 FY 10-K 2023-03-15 0001410578-23-000267
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.58M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 2.60M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 135,686 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 492,270 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 1.41M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 2,134 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 114.91M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 484,136 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 1.90M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-15 0001410578-23-000267
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 296,362 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-14 0001410578-24-000198
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 1.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 75,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 17,521 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-13 0001410578-25-000336
us-gaap Assets Assets USD 34.75M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap AssetsCurrent Assets, Current USD 34.40M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 10.10M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 10.10M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -1.79M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001104659-25-107785
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 6.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 8.90M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 16.13 2023-12-31 2024 FY 10-K 2025-03-13 0001410578-25-000336
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 33,333 2022-07-14 2023 FY 10-K 2024-03-14 0001410578-24-000198
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 5.00B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 168.15M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 168.15M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap CommonStockValue Common Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -15.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap ConvertibleDebtFairValueDisclosures Convertible Debt, Fair Value Disclosures USD 1.21M 2020-12-31 2021 FY 20-F 2022-04-14 0001104659-22-045620
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 12.00M 2021-10-28 2023 FY 10-K 2024-03-14 0001410578-24-000198
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 50,000 2022-09-30 2022 Q3 6-K 2022-11-10 0001410578-22-003102
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 32,583 2023-12-31 2024 FY 10-K 2025-03-13 0001410578-25-000336
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 67,540 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 12.01M 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 2.26M 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 8.58M 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 10,218 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 433,736 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 1.41M 2021-12-31 2022 FY 10-K 2023-03-15 0001410578-23-000267
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 540,155 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 119,524 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap DeferredTaxAssetsUnrealizedCurrencyLosses Deferred Tax Assets, Unrealized Currency Losses USD 3,482 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 12.01M 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap DueToOfficersOrStockholdersCurrent Due to Officers or Stockholders, Current USD 650,000 2023-03-31 2023 Q1 10-Q 2023-05-09 0001410578-23-000940
us-gaap DueToOfficersOrStockholdersNoncurrent Due to Officers or Stockholders, Noncurrent USD 3.37M 2023-03-31 2023 Q1 10-Q 2023-05-09 0001410578-23-000940
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 4.02M 2023-03-31 2023 Q1 10-Q 2023-05-09 0001410578-23-000940
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 4.72M 2021-12-31 2021 FY 20-F 2022-04-14 0001104659-22-045620
us-gaap DueToRelatedPartiesNoncurrent Due to Related Parties, Noncurrent USD 3.52M 2022-12-31 2022 FY 10-K 2023-03-15 0001410578-23-000267
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.01 2021-01-01 2021-12-31 2021 FY 20-F 2022-04-14 0001104659-22-045620
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.01 2021-01-01 2021-12-31 2021 FY 20-F 2022-04-14 0001104659-22-045620
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.031 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 2,747 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 6.30M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -77,237 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-14 0001410578-24-000198
us-gaap FinancingInterestExpense Financing Interest Expense USD 275,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-15 0001410578-23-000267
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 691,666 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 288,000 2022-12-31 2022 FY 10-K 2023-03-15 0001410578-23-000267
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 25,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 104,000 2022-09-30 2022 Q3 6-K 2022-11-10 0001410578-22-003102
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 83,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 308,334 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 416,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-14 0001410578-24-000198
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 18,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-13 0001410578-25-000336
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -15.72M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -15.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -81,742 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 2.25M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD -397,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -3.32M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 208,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-13 0001410578-25-000336
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 208,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 489,322 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 80,482 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 117,103 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD -311,670 2022-01-01 2022-06-30 2022 Q2 6-K 2022-08-18 0001410578-22-002665
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -6,803 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 308,334 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap InterestExpense Interest Expense USD 268,111 2021-01-01 2021-06-30 2022 Q2 6-K 2022-08-18 0001410578-22-002665
us-gaap InterestExpenseDebtExcludingAmortization Interest Expense, Debt, Excluding Amortization USD 187,000 2022-01-01 2022-09-30 2022 Q3 6-K 2022-11-10 0001410578-22-003102
us-gaap InterestIncomeOther Interest Income, Other USD 536,068 2023-01-01 2023-09-30 2023 Q2 10-Q 2023-11-09 0001410578-23-002320
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 393,611 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-15 0001410578-23-000267
us-gaap InterestPayableCurrent Interest Payable, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 1.15M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001104659-25-107785
us-gaap InvestmentIncomeInterestAndDividend Investment Income, Interest and Dividend USD 372,840 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap Investments Investments USD 3.58M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001104659-25-107785
us-gaap Liabilities Liabilities USD 6.05M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 34.75M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap LiabilitiesCurrent Liabilities, Current USD 4.78M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap LiabilitiesFairValueAdjustment Liabilities, Fair Value Adjustment USD -1.25M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-15 0001410578-23-000267
us-gaap LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value USD 666,667 2020-02-01 2020-02-29 2022 FY 10-K 2023-03-15 0001410578-23-000267
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 28.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -7.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -13.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -15.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -8.69M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0001410578-24-000198
us-gaap NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 Noncash or Part Noncash Acquisition, Intangible Assets Acquired USD 1.00M 2019-01-01 2019-12-31 2021 FY 20-F 2022-04-14 0001104659-22-045620
us-gaap NoncurrentAssets Long-Lived Assets ILS 1.92M 2021-06-30 2021 Q2 6-K 2021-08-24 0001213900-21-044599
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 288,260 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 15.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 6.48M 2021-12-31 2021 FY 20-F 2022-04-14 0001104659-22-045620
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 170,780 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap OtherAssets Other Assets USD 50,000 2021-12-31 2022 FY 10-K 2023-03-15 0001410578-23-000267
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 2,747 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -613 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap OtherIncome Other Income ILS 22.33M 2019-01-01 2019-12-31 2019 FY 20-F 2020-04-03 0001213900-20-008493
us-gaap OtherLiabilities Other Liabilities USD 1.87M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 600,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 1.27M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 129,948 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 1.40M 2021-10-28 2021 FY 20-F 2022-04-14 0001104659-22-045620
us-gaap PaymentsOfLoanCosts Payments of Loan Costs USD 50,000 2021-01-01 2021-06-30 2022 Q2 6-K 2022-08-18 0001410578-22-002665
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 164,578 2021-01-01 2021-09-30 2022 Q3 6-K 2022-11-10 0001410578-22-003102
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 23.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap PrepaidExpenseAndOtherAssets Prepaid Expense and Other Assets USD 1.26M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 1.22M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 602,652 2025-09-30 2025 Q3 10-Q 2025-11-06 0001104659-25-107785
us-gaap PrepaidExpenseCurrentAndNoncurrent Prepaid Expense USD 63,219 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 38,643 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap PrepaidInsurance Prepaid Insurance USD 68,680 2025-09-30 2025 Q3 10-Q 2025-11-06 0001104659-25-107785
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 28.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 7.00M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-15 0001410578-23-000267
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 3.48M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-15 0001410578-23-000267
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 139,285 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-15 0001410578-23-000267
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 15.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 204,035 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -15.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 311,670 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-14 0001410578-24-000198
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 450,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 9.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -86.21M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 0 2021-01-01 2021-12-31 2021 FY 20-F 2022-04-14 0001104659-22-045620
us-gaap RoyaltyIncomeNonoperating Royalty Income, Nonoperating USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 5.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 1.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 7.35 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.187 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.04 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2025-06-30 2025 Q2 10-Q 2025-08-07 0001410578-25-001613
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 20.80M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 0.48 2024-12-31 2024 FY 10-K 2025-03-13 0001410578-25-000336
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-09 0001410578-23-000940
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 1,650 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-13 0001410578-25-000336
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0.77 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-09 0001410578-23-000940
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Other Share Increase (Decrease) in Period, Weighted Average Exercise Price USD/shares 137.5 2021-01-01 2021-12-31 2022 Q2 6-K 2022-08-18 0001410578-22-002665
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 1,972 2022-06-30 2022 Q2 6-K 2022-08-18 0001410578-22-002665
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 309,114 2022-06-30 2022 Q2 6-K 2022-08-18 0001410578-22-002665
us-gaap SharePrice Share Price USD/shares 7.35 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap ShortTermInvestments Short-term Investments USD 23.08M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 28.70M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 1.67 2023-11-08 2024 Q3 10-Q 2024-11-08 0001410578-24-001804
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 14.88M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-15 0001410578-23-000267
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 1.15M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 28.00M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap TradingSecurities Debt Securities, Trading, and Equity Securities, FV-NI USD 14.90M 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 2.93M 2022-12-31 2023 FY 10-K 2024-03-14 0001410578-24-000198
us-gaap TreasuryStockSharesAcquired Treasury Stock, Shares, Acquired shares 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0001410578-24-000198
us-gaap TreasuryStockSharesRetired Treasury Stock, Shares, Retired shares 45 2023-11-01 2023-11-30 2024 FY 10-K 2025-03-13 0001410578-25-000336
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD -84,580 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123342
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 67,063 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-13 0001410578-25-001226
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 3.55M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001104659-26-035251
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 373,599 2021-12-31 2022 FY 10-K 2023-03-15 0001410578-23-000267
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 1.58B 2021-01-01 2021-12-31 2021 FY 20-F 2022-04-14 0001104659-22-045620
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 1.58B 2021-01-01 2021-12-31 2021 FY 20-F 2022-04-14 0001104659-22-045620

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →